Tapentadol is a centrally acting opioid analgesic registered for use in Australia to treat moderate to severe pain. A recent review has suggested a lack of data regarding ‘abuse, dependence, diversion, or recreational use’ of tapentadol. This paper addresses this research gap by examining patterns of tapentadol use among a sentinel sample of people who regularly inject drugs in Australia.